SMS Pharmaceuticals Ltd posts consolidated Q1FY26 net profit of Rs. 20.49 crores

SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 196.6402 crores during the period ended June 30, 2025 as compared to Rs. 249.6197 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 20.4905 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 20.3154 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 2.31 for the period ended June 30, 2025 as compared to Rs. 2.40 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 196.6402 crs	₹249.6197 crs	-21.22%
Net Profit	₹20.4905 crs	₹20.3154 crs	0.86%
EPS	₹2.31	₹2.40	-3.75%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 196.6402 crores during the period ended June 30, 2025 as compared to Rs.165.8189 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.20.4905 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.16.4794 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.2.31 for the period ended June 30, 2025 as compared to Rs.1.95 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 196.6402 crs	₹165.8189 crs	18.59%
Net Profit	₹20.4905 crs	₹16.4794 crs	24.34%
EPS	₹2.31	₹1.95	18.46%

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 223.95 as compared to the previous close of Rs. 214.45. The total number of shares traded during the day was 5852 in over 275 trades.

The stock hit an intraday high of Rs. 225.70 and intraday low of 215.00. The net turnover during the day was Rs. 1290493.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals Q1FY26 Q1FY2026 FY2026 ResultUpdate